As a world leader in in vitro diagnostics, QuidelOrtho Corporation (Nasdaq: QDEL) develops and manufactures intelligent solutions that transform data into understanding and action for more people in more places every day.
QuidelOrtho offers industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic. So that patients, clinicians and health officials can spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence.
Building upon an 80-year legacy of groundbreaking innovation, QuidelOrtho continues to partner with customers across the healthcare continuum and around the globe featuring the leading brands QuickVue®, Sofia®, Triage®, Vitros®, and Savanna®.